InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2018-12-07 | Greg Gianforte | house | Sale | $100,001 - $250,000 |
| 2018-11-30 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| 2018-11-29 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| 2017-05-30 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
No financial data available for CSLLY.
Company may not file with SEC or CIK is unresolved.
CSL Restructure And Seqirus Split Reset Expectations After Share Price Slide
CSLLY vs. ACAD: Which Stock Is the Better Value Option?
CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?
Top and lowest-rated large-cap stocks heading into earnings
Kamada: From Buy To Hold After 22.4% Surge (Rating Downgrade)
CSLLY or ARGX: Which Is the Better Value Stock Right Now?
CSLLY vs. ARGX: Which Stock Is the Better Value Option?
Highest and lowest quant-rated healthcare stocks above $10B cap after earnings season
KalVista Pharmaceuticals: Has Potential But With Caveats
CSL Expands U.S. Manufacturing And Secures Canadian Vaccine Contract As Shares Slide
CSL announces expansion of Illinois plasma therapy manufacturing facility
Canada and CSL Seqirus, a Global Leader in Influenza Vaccines, agree on new Pandemic Preparedness Contract